164MO Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results
In: Annals of Oncology, Jg. 31 (2020-09-01), S. S306
Online
unknown
Zugriff:
Titel: |
164MO Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results
|
---|---|
Autor/in / Beteiligte Person: | Bartels, Stephan ; Kreipe, Hans-Heinrich ; Braun, Michael ; Gluz, O ; Kandt, L. ; Christgen, Henriette ; Gräser, M. ; Aktas, Bahriye ; Christgen, Matthias ; Grote, Isabel ; Wuerstlein, Rachel ; Harbeck, Nadia ; Grischke, E-M. ; Lüdtke-Heckenkamp, K. ; Kümmel, S ; Nitz, U. ; Bollmann, L. ; Gronewold, Malte ; Schumacher, Claudia ; Kates, R |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 31 (2020-09-01), S. S306 |
Veröffentlichung: | Elsevier BV, 2020 |
Medientyp: | unknown |
ISSN: | 0923-7534 (print) |
DOI: | 10.1016/j.annonc.2020.08.286 |
Schlagwort: |
|
Sonstiges: |
|